Cite
HARVARD Citation
Shafique, M. et al. (2019). A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer. Oncologist. pp. 887-e416. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shafique, M. et al. (2019). A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer. Oncologist. pp. 887-e416. [Online].